PYRAZINE DERIVATIVES AS ENAC BLOCKERS

and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have the meanings as indicated in the specification, are useful for treating diseases mediated by blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BHALAY Gurdip, HOWSHAM Catherine, EDWARDS Lee, HUNT Peter, SMITH Nichola
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BHALAY Gurdip
HOWSHAM Catherine
EDWARDS Lee
HUNT Peter
SMITH Nichola
description and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have the meanings as indicated in the specification, are useful for treating diseases mediated by blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2017143705A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2017143705A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2017143705A13</originalsourceid><addsrcrecordid>eNrjZFANiAxyjPL0c1VwcQ3yDHMM8QxzDVZwDFZw9XN0VnDy8Xf2dg0K5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaG5oYmxuYGpo6GxsSpAgAxbCQ0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRAZINE DERIVATIVES AS ENAC BLOCKERS</title><source>esp@cenet</source><creator>BHALAY Gurdip ; HOWSHAM Catherine ; EDWARDS Lee ; HUNT Peter ; SMITH Nichola</creator><creatorcontrib>BHALAY Gurdip ; HOWSHAM Catherine ; EDWARDS Lee ; HUNT Peter ; SMITH Nichola</creatorcontrib><description>and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have the meanings as indicated in the specification, are useful for treating diseases mediated by blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170525&amp;DB=EPODOC&amp;CC=US&amp;NR=2017143705A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170525&amp;DB=EPODOC&amp;CC=US&amp;NR=2017143705A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BHALAY Gurdip</creatorcontrib><creatorcontrib>HOWSHAM Catherine</creatorcontrib><creatorcontrib>EDWARDS Lee</creatorcontrib><creatorcontrib>HUNT Peter</creatorcontrib><creatorcontrib>SMITH Nichola</creatorcontrib><title>PYRAZINE DERIVATIVES AS ENAC BLOCKERS</title><description>and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have the meanings as indicated in the specification, are useful for treating diseases mediated by blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFANiAxyjPL0c1VwcQ3yDHMM8QxzDVZwDFZw9XN0VnDy8Xf2dg0K5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaG5oYmxuYGpo6GxsSpAgAxbCQ0</recordid><startdate>20170525</startdate><enddate>20170525</enddate><creator>BHALAY Gurdip</creator><creator>HOWSHAM Catherine</creator><creator>EDWARDS Lee</creator><creator>HUNT Peter</creator><creator>SMITH Nichola</creator><scope>EVB</scope></search><sort><creationdate>20170525</creationdate><title>PYRAZINE DERIVATIVES AS ENAC BLOCKERS</title><author>BHALAY Gurdip ; HOWSHAM Catherine ; EDWARDS Lee ; HUNT Peter ; SMITH Nichola</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2017143705A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2017</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>BHALAY Gurdip</creatorcontrib><creatorcontrib>HOWSHAM Catherine</creatorcontrib><creatorcontrib>EDWARDS Lee</creatorcontrib><creatorcontrib>HUNT Peter</creatorcontrib><creatorcontrib>SMITH Nichola</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BHALAY Gurdip</au><au>HOWSHAM Catherine</au><au>EDWARDS Lee</au><au>HUNT Peter</au><au>SMITH Nichola</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRAZINE DERIVATIVES AS ENAC BLOCKERS</title><date>2017-05-25</date><risdate>2017</risdate><abstract>and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have the meanings as indicated in the specification, are useful for treating diseases mediated by blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2017143705A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title PYRAZINE DERIVATIVES AS ENAC BLOCKERS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T21%3A27%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BHALAY%20Gurdip&rft.date=2017-05-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2017143705A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true